Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 240 publications
Claudin-6 as a potential target in the treatment of ovarian cancer: a review of emerging drugs.
Journal: Expert opinion on emerging drugs
Published: July 17, 2026
Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes.
Journal: Gynecologic oncology
Published: June 19, 2026
Reply to Hojný et al.: Fusion-driven vs. fusion-negative high-grade endometrial stromal sarcoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 18, 2026
Preclinical in vitro and in vivo activity of trastuzumab deruxtecan against ERBB2-mutated cervical carcinomas with low HER2 expression.
Journal: Gynecologic oncology reports
Published: June 03, 2026
Activity of datopotamab deruxtecan in TROP2-expressing low-grade serous ovarian cancer: a preclinical study.
Journal: Gynecologic oncology reports
Published: April 29, 2026
Response regarding "Folate receptor alpha as a successful biomarker in the treatment of low-grade serous ovarian cancer patients using pre-clinical and clinical models" by Wu et al.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 19, 2026
Integrated mutational landscape analysis of endometrial stromal sarcoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 27, 2026
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775.
Journal: Journal for immunotherapy of cancer
Published: January 20, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2026
Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 17, 2025
Last Updated: 09/26/2026